Mediators of Inflammation

Mediators of Inflammation / 2019 / Article

Corrigendum | Open Access

Volume 2019 |Article ID 8247280 | 1 page | https://doi.org/10.1155/2019/8247280

Corrigendum to “CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy”

Received11 Jul 2019
Accepted15 Jul 2019
Published23 Sep 2019

In the article titled “CD36-Mediated Lipid Accumulation and Activation of NLRP3 Inflammasome Lead to Podocyte Injury in Obesity-Related Glomerulopathy” [1], there were some input errors in Table 3 as the unit of kidney weight “mg,” Lee’s index “g/cm,” and urinary protein “mg/d” are wrong and should be corrected as kidney weight “g,” Lee’s index “g1/3/cm,” and urinary protein “μg/d.” The corrected version of Table 3 is as follows:


GroupControlModel

Body weight (g)
Kidney weight (g)
Lee’s index (g1/3/cm)
Visceral fat index
Urinary protein (μg/d)
Serum creatinine (μmol/L)
Creatinine clearance rate (mL/min)
Serum triglyceride (mmol/L)
Serum cholesterol (mmol/L)
Blood glucose (mmol/L)

vs. control group.

The authors apologize for these errors and confirm that they do not affect the conclusions or the results of this article.

References

  1. J. Zhao, H.-l. Rui, M. Yang, L.-j. Sun, H.-r. Dong, and H. Cheng, “CD36-mediated lipid accumulation and activation of NLRP3 inflammasome lead to podocyte injury in obesity-related glomerulopathy,” Mediators of Inflammation, vol. 2019, Article ID 3172647, 16 pages, 2019. View at: Publisher Site | Google Scholar

Copyright © 2019 Jing Zhao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

280 Views | 209 Downloads | 0 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.